Your browser doesn't support javascript.
loading
Pediatric Vogt-Koyanagi-Harada [VKH]-Associated Panuveitis: Clinical Course and Management
Bina Journal of Ophthalmology. 2006; 11 (4): 505-513
em Persa | IMEMR | ID: emr-76269
ABSTRACT
To assess the clinical course, determine the efficacy and safety of oral methotrexate in the control of intraocular inflammation and evaluate the outcomes of lensectomy-vitrectomy and goniosynechiolysis in pediatric VKH-associated panuveitis. In this retrospective non-comparative interventional case series, 10 patients [20 eyes] with pediatric VKH-associated panuveitis [onset of disease at age 14 years or younger] were studied. All patients underwent stepwise medical treatment consisting of oral prednisolone [0.5-1 mg/kg], supplemented by oral methotrexate [5-7.5 mg/wk] in refractory cases. Surgical intervention was performed for complications such as visually significant cataracts and secondary glaucoma and included pars plana lensectomy-vitrectomy and peripheral anterior synechiolysis in a one-stage procedure. Control of inflammation, corticosteroid requirement, visual acuity, and intraocular pressure [IOP] were the main outcome measures. Ten consecutive patients with minimum follow up of six months were analyzed. All patients were initially treated with oral corticosteroids; methotrexate was additionally required in six subjects. In all eyes, inflammation decreased and vision was preserved or improved. Side effects of methotrexate were mild and transient. Nine eyes of five patients underwent combined lensectomy and vitrectomy. The procedure was successful in all eyes without any exacerbation of inflammation. Eight eyes had elevated IOP, six of which underwent peripheral anterior synechiolysis at the time of lensectomy-vitrectomy. IOP was controlled after the procedure in all eyes with timolol only. Overall, final visual acuity was eyes and <20/200 in only 20%. Pediatric VKH-associated panuveitis seems to follow an aggressive course; the rate of cataracts and secondary glaucoma seems to be high. Oral methotrexate is a safe and effective adjunct and displays steroid-sparing properties in the control of inflammation. Surgical interventions including peripheral anterior synechiolysis in addition to pars plana lensectomy and vitrectomy may be effective in controlling IOP in eyes with cataract and glaucoma
Assuntos
Buscar no Google
Índice: IMEMR (Mediterrâneo Oriental) Assunto principal: Vitrectomia / Catarata / Pan-Uveíte / Glaucoma / Metotrexato / Estudos Retrospectivos / Gerenciamento Clínico Limite: Humanos Idioma: Persa Revista: Bina J. Ophthalmol. Ano de publicação: 2006

Similares

MEDLINE

...
LILACS

LIS

Buscar no Google
Índice: IMEMR (Mediterrâneo Oriental) Assunto principal: Vitrectomia / Catarata / Pan-Uveíte / Glaucoma / Metotrexato / Estudos Retrospectivos / Gerenciamento Clínico Limite: Humanos Idioma: Persa Revista: Bina J. Ophthalmol. Ano de publicação: 2006